Employee Participation

According to the report, employer spending on GLP-1 drugs doubled in a single year, rising from $11 to $24 per member per month. GLP-1s now account for 10.5% of all prescription drug claims, up from 6.9% in 2023.

A federal court decision voids the fee as an unlawful tax imposed without congressional authorization, resetting compliance expectations for employers and setting up a likely appeal.

"It is concerning that some workers, especially Gen Z, are reducing their 401(k) contributions due to rising medical insurance premiums," said Kimberly Landry, research director at LIMRA.

Brokers and carriers looking to grow their blocks of business should consider broadening their target markets to take advantage of the significant potential at both ends of the voluntary/worksite industry.

One in five U.S. adults believes they will never achieve financial independence.

This gap represents a growing risk for HR leaders who rely on self-attestation or course completion data to gauge workforce readiness.